MVAL
VanEck Morningstar Wide Moat Value ETF
MVAL tracks a modified equal-weighted index of 30 to 60 value-oriented US stocks that Morningstar determines to be attractively priced and have sustainable competitive advantages.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 1.9 M
ASSETS UNDER MGMT
49 bp
EXPENSES
Fund Basics
| Inception date | Mar 26, 2024 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| BROWN-FORMAN CORP-CLASS B | 4.8 % |
| KENVUE, INC. | 4.7 % |
| ZIMMER HOLDINGS INC | 4.5 % |
| DANAHER CORP | 4.5 % |
| CONSTELLATION BRANDS INC-A | 4.4 % |
| BRISTOL-MYERS SQUIBB CO | 4.4 % |
| CLOROX COMPANY | 4.1 % |
| GE HEALTHCARE TECHNOLOGIES INC. | 3.6 % |
| MASCO CORP | 3.1 % |
| NIKE INC -CL B | 2.9 % |
Constituent Breakdown
| Number of holdings | 47 |
| Herfindahl-Hirschman Index | 305 |
| Wgt avg mkt cap (mns) | $119,062 |
| Large cap (>$10bn) | 87.3% |
| Mid cap ($2-10bn) | 12.6% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 99.9% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 95.4 % |
 |
NETHERLANDS | 2.2 % |
 |
ARGENTINA | 1.2 % |
 |
IRELAND | 1.2 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 0.8% | 12.7% | 10.7% | -- | -- | -- | -- | 8.0% |
| Dividend Yield | 0.0% | 2.0% | 1.5% | -- | -- | -- | -- | 1.3% |
| Total Returns | 0.8% | 14.6% | 12.2% | -- | -- | -- | -- | 9.3% | Ann. Volatility | 14.3% | 13.9% | 15.9% | -- | -- | -- | -- | 15.4% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.61 | 30% |
| MSCI EAFE | 0.54 | 38% |
| MSCI Emg Mkts | 0.24 | 16% |
Liquidity Measures
| Avg. volume (000) | 1 |
| ADV traded (mns) | $0 |
| Turnover | 2.0% |
| Avg. Bid/Ask (% of price) | 0.32% |
Technical Indicators
| 30d moving avg. (EMA) | $36.32 |
| Relative strength (RSI) | 57 |
| MACD/Signal | 0.28/0.19 |
| Bollinger Bands (Upper/Lower) | $37.30/$35.44 |
| Short interest (% of AUM) | 0.0% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. MVAL |
Expenses vs. MVAL |
ALTAR Score™ vs. MVAL |
|---|---|---|---|---|
| MOAT | VanEck Morningstar Wide Moat ETF | 59.5% | -3 bp | -0.7% |
| MOTG | VanEck Morningstar Global Wide Moat ETF | 24.4% | +3 bp | +2.5% |
| LVDS | JPMorgan Fundamental Data Science Large Value ETF | 23.5% | 0 bp | -1.3% |
| RSPS | Invesco S&P 500 Equal Weight Consumer Staples ETF | 20.8% | -9 bp | +0.5% |
| SMOT | VanEck Morningstar SMID Moat ETF | 19.4% | 0 bp | +0.4% |
| AQEC | AQE Core ETF | 16.9% | 0 bp | -0.6% |
| FTXG | First Trust Nasdaq Food & Beverage ETF | 15.8% | +11 bp | +1.0% |
| FDL | First Trust Morningstar Dividend Leaders Index Fund | 15.2% | -4 bp | +4.5% |
| QFHD | Pacer S&P 500 Quality FCF High Dividend ETF | 15.1% | 0 bp | +1.6% |
| MAVF | Matrix Advisors Value ETF | 13.7% | +26 bp | -1.3% |
Risk and Returns: MVAL vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/5/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.6%
ALTAR SCORE™
73rd
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,395 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. MVAL's ALTAR Score™ is approximately 0.6 standard
deviations above the category average. This places MVAL in the 73rd percentile
among funds in the category.
Sell-Side Consensus
$45.03
PRICE TARGET
+20.4%
UPSIDE